HIV and hepatitis C virus infection in the United States: whom and how to test

Clin Infect Dis. 2014 Sep 15;59(6):875-82. doi: 10.1093/cid/ciu396. Epub 2014 May 27.

Abstract

In the United States, of the 1.1 million persons infected with human immunodeficiency virus (HIV) and the 2.7 million infected with hepatitis C virus (HCV), approximately 16% and 50%, respectively, are unaware of their infection. Highly effective treatments have turned both diseases into manageable conditions, and in the case of hepatitis C, a disease that can be cured. Early diagnosis is imperative so that infected persons can take measures to stay healthy, get into care, benefit from therapy, and reduce the risk of transmission. In this report, we review current recommendations provided by the Centers for Disease Control and Prevention (CDC) and the United States Preventive Services Task Force on whom to screen for HIV and HCV infections, and recommendations from the CDC, the Association of Public Health Laboratories, and the Clinical and Laboratory Standards Institute on how to test for these infections.

Keywords: HCV; HIV; hepatitis C virus; nucleic acid test; testing algorithm.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Centers for Disease Control and Prevention, U.S.
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / epidemiology*
  • HIV* / physiology
  • Hepacivirus* / physiology
  • Hepatitis C / diagnosis
  • Hepatitis C / epidemiology*
  • Humans
  • Male
  • Mass Screening / legislation & jurisprudence
  • Mass Screening / methods
  • Mass Screening / standards
  • United States / epidemiology
  • United States Food and Drug Administration